LYSOGENE
LYS | PA
Overview
Corporate Details
- ISIN(s):
- FR0013233475
- LEI:
- 969500T64RILK1RD0852
- Country:
- France
- Address:
- 18 RUE JACQUES DULUD, 92200 NEUILLY-SUR-SEINE
- Website:
- https://www.lysogene.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Lysogene’s determination to succeed is rooted in our deep understanding of the impact central nervous system (CNS) diseases have on patients and families, and springs from our founder whose own child was affected by a neurodegenerative disease. Our mission is to discover and develop innovative therapies to transform the lives of people with rare central nervous system disorders. Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for LYSOGENE and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-05-26 17:32 |
Delisting Announcement
Informations privilégiées / Autres communiqués
|
French | 84.9 KB | |
| 2023-05-26 17:32 |
Delisting Announcement
Inside Information / Other news releases
|
English | 83.2 KB | |
| 2023-05-26 10:00 |
Delisting Announcement
Informations privilégiées / Autres communiqués
|
French | 85.6 KB | |
| 2023-05-26 10:00 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 83.5 KB | |
| 2023-05-15 18:00 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 83.5 KB | |
| 2023-05-15 18:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 85.6 KB | |
| 2023-04-29 18:00 |
Report Publication Announcement
Inside Information / News release on accounts, results
|
English | 82.9 KB | |
| 2023-04-29 18:00 |
Delisting Announcement
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 85.1 KB | |
| 2023-04-14 18:00 |
M&A Activity
Inside Information / Other news releases
|
English | 83.2 KB | |
| 2023-04-14 18:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 85.4 KB | |
| 2023-03-24 20:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 95.8 KB | |
| 2023-03-24 20:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 93.5 KB | |
| 2023-02-16 18:00 |
Delisting Announcement
Inside Information / Other news releases
|
English | 107.8 KB | |
| 2023-02-16 18:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 110.2 KB | |
| 2023-02-03 18:00 |
Board/Management Information
Informations privilégiées / Autres communiqués
|
French | 91.3 KB |
Automate Your Workflow. Get a real-time feed of all LYSOGENE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for LYSOGENE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
